Switch to unified view

a b/clusters/9knumclustersv2/clust_1163.txt
1
INR > .
2
INR < . (or <  on anticoagulants)
3
INR < .  ULN
4
INR ?. ULN
5
INR ? .
6
INR < .  ULN
7
INR ? . x ULN;
8
INR ?.
9
INR > 
10
INR >= 
11
INR and APTT ? . x ULN.
12
INR > .
13
INR =< .
14
Low-dose Coumadin ( mg) is acceptable; however, doses that increase INR are not permitted; if an alternative to Coumadin-based anticoagulants cannot be used, the INR should be monitored weekly after initiation of therapy and upon discontinuation of INCB, until INR normalization
15
Low-dose Coumadin ( mg) is acceptable; however, doses that increase INR are not permitted; if an alternative to Coumadin-based anticoagulants cannot be used, the INR should be monitored weekly after initiation of therapy and upon discontinuation of INCB, until INR normalization
16
INR < .
17
Coagulation  INR less than or equal to . x ULN (or in range INR, usually between  and , if a patient is on a stable dose of therapeutic warfarin).
18
INR < .  ULN
19
INR and aPTT < . X ULN unless on medication known to alter INR and aPTT.
20
INR . to ULN or ?  for subjects receiving anticoagulant therapy
21
INR < .  ULN
22
INR and aPTT within . ULN
23
INR > .
24
INR ? ,
25
INR > . (or >  if on anticoagulant therapy)
26
Most recent INR prior to surgery > .